| Released | Contributor | Author | Title | Pages | Price |
| 30-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for RMTI | 13 |
$25 |
| 29-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Rockwell Med Tech has a current Overall Rating of C (Neutral). | 7 |
$25 |
| 29-Nov-2009 | Wright Reports |
N/A
| Wright Investors Service Comprehensive Report for Rockwell Medical Technologies, Inc. | 41 |
$65 |
| 28-Nov-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: ROCKWELL MED TECHNOLOGIES | 5 |
$25 |
| 28-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Drug Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards. | 65 |
$20 |
| 28-Nov-2009 | Standard & Poor's Quantitative Report |
N/A
| Rockwell Medical Tech | 6 |
$25 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | ROCKWELL MEDICAL TECHNOLOGIES INC (RMTI=US) 2-weeks forecast | 1 |
$10 |
| 27-Nov-2009 | Pechala's Reports | Frantisek Pechala | ROCKWELL MEDICAL TECHNOLOGIES INC (RMTI=US) 12-months forecast | 1 |
$15 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ELGX , HCCI , ILMN , OCLS , RMTI -- MEDICAL SUPPLIES & EQUIPMENT | 3 |
$4 |
0.34% Nasdaq 
Research Reports
